Literature DB >> 15985441

The death rate among hospitalized heart failure patients with normal and depressed left ventricular ejection fraction in the year following discharge: evolution over a 10-year period.

Lilian Grigorian Shamagian1, Jose Ramon Gonzalez-Juanatey, Alfonso Varela Roman, Jose Maria Garcia Acuña, Alejandro Virgós Lamela.   

Abstract

AIMS: To investigate whether changes in clinical characteristics and treatment strategies between 1991 and 2001 have had an impact on the survival of patients hospitalized with congestive heart failure (CHF) and whether those with normal left ventricular ejection fraction (LVEF> or =50%) differ in this respect from those with depressed LVEF. METHODS AND
RESULTS: We studied 1482 patients who had been admitted to the Cardiology Service of a tertiary Spanish hospital in the last 10 years with CHF. Among the 1110 for whom LVEF was evaluated, the prevalence of normal LVEF rose from 37% in the period 1991-96 (Period 1) to 47% in the period 2000-2001 (Period 3). The intensity of both diagnostic and therapeutic measures also increased during this 10-year period. The 1-year survival rate remained virtually unchanged in the whole group of patients, being 82, 84, and 82% in Periods 1, 2 (1997-99), and 3, respectively, even though the prognosis of patients with depressed LVEF (<50%) improved significantly, with 1-year survival rates of 76, 77, and 84% in Periods 1, 2, and 3, respectively; the normal LVEF group had decreasing 1-year survival rates of 88, 86, and 81% in Periods 1, 2, and 3, respectively, although the increased risk of death was not statistically significant.
CONCLUSION: Although in our centre the death rate among hospitalized CHF patients with depressed LVEF during the first year after discharge has tended to fall over the past 10 years, application of current clinical guidelines has led to no such decrease for patients with normal LVEF. This situation points to a need to reconsider the diagnostic and therapeutic strategy to be employed with this latter group of patients.

Entities:  

Mesh:

Year:  2005        PMID: 15985441     DOI: 10.1093/eurheartj/ehi383

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  8 in total

1.  Congestion is the driving force behind heart failure.

Authors:  Maya Guglin
Journal:  Curr Heart Fail Rep       Date:  2012-09

2.  The restoration of chronotropic competence in heart failure patients with normal ejection fraction (RESET) study: rationale and design.

Authors:  David A Kass; Dalane W Kitzman; Guy E Alvarez
Journal:  J Card Fail       Date:  2009-10-07       Impact factor: 5.712

3.  Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute.

Authors:  Douglas S Lee; Philimon Gona; Ramachandran S Vasan; Martin G Larson; Emelia J Benjamin; Thomas J Wang; Jack V Tu; Daniel Levy
Journal:  Circulation       Date:  2009-06-08       Impact factor: 29.690

4.  Diuretics as pathogenetic treatment for heart failure.

Authors:  Maya Guglin
Journal:  Int J Gen Med       Date:  2011-01-23

5.  Relationship between B-type natriuretic peptide serum level, echocardiographic TEI index and the degree of diastolic dysfunction in patients with heart failure with preserved systolic function.

Authors:  Danuta Karasek; Władysław Sinkiewicz; Jan Błażejewski
Journal:  Arch Med Sci       Date:  2011-07-11       Impact factor: 3.318

6.  Temporal variation in the prognosis and treatment of advanced heart failure - before and after 2000.

Authors:  Carlos Henrique Del Carlo; Juliano Novaes Cardoso; Marcelo Eidi Ochia; Mucio Tavares de Oliveira; José Antonio Franchini Ramires; Antonio Carlos Pereira-Barretto
Journal:  Arq Bras Cardiol       Date:  2014-04-17       Impact factor: 2.000

7.  Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain.

Authors:  A Salinas-Botrán; J Sanz-Cánovas; J Pérez-Somarriba; L M Pérez-Belmonte; L Cobos-Palacios; M Rubio-Rivas; S de-Cossío-Tejido; J M Ramos-Rincón; M Méndez-Bailón; R Gómez-Huelgas
Journal:  Rev Clin Esp (Barc)       Date:  2021-10-08

8.  [Clinical characteristics and risk factors for mortality upon admission in patients with heart failure hospitalized due to COVID-19 in Spain].

Authors:  A Salinas-Botrán; J Sanz-Cánovas; J Pérez-Somarriba; L M Pérez-Belmonte; L Cobos-Palacios; M Rubio-Rivas; S de-Cossío-Tejido; J M Ramos-Rincón; M Méndez-Bailón; R Gómez-Huelgas
Journal:  Rev Clin Esp       Date:  2021-07-17       Impact factor: 3.064

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.